GR Burmester

1.1k total citations
28 papers, 495 citations indexed

About

GR Burmester is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, GR Burmester has authored 28 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 11 papers in Immunology and 5 papers in Genetics. Recurrent topics in GR Burmester's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Chronic Lymphocytic Leukemia Research (5 papers). GR Burmester is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Chronic Lymphocytic Leukemia Research (5 papers). GR Burmester collaborates with scholars based in Germany, United States and Poland. GR Burmester's co-authors include Thomas Dörner, Falk Hiepe, Annett M. Jacobi, Andreas Radbruch, Karl Egerer, Ute Rohr, Bimba F. Hoyer, Henrik E. Mei, K. Thiele and Imtiaz M Mumtaz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Value in Health.

In The Last Decade

GR Burmester

26 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
GR Burmester Germany 10 310 248 66 54 52 28 495
A M Delgado-Vega Sweden 12 278 0.9× 273 1.1× 64 1.0× 60 1.1× 12 0.2× 20 485
JT Merrill United States 9 494 1.6× 383 1.5× 191 2.9× 66 1.2× 17 0.3× 26 664
Vicente Baca Mexico 14 343 1.1× 321 1.3× 53 0.8× 78 1.4× 21 0.4× 21 681
Maiko Yoshikawa Japan 11 340 1.1× 342 1.4× 69 1.0× 68 1.3× 9 0.2× 15 550
Tiina M. Järvinen Finland 10 121 0.4× 158 0.6× 38 0.6× 88 1.6× 50 1.0× 14 389
Vasileios Vazgiourakis Greece 10 200 0.6× 252 1.0× 52 0.8× 57 1.1× 9 0.2× 25 431
F Navaux France 6 202 0.7× 133 0.5× 39 0.6× 65 1.2× 8 0.2× 9 357
Isabelle Lemaire France 5 187 0.6× 105 0.4× 84 1.3× 79 1.5× 26 0.5× 6 343
CWK Lam China 4 260 0.8× 354 1.4× 18 0.3× 64 1.2× 8 0.2× 5 474
Gro Østli Eilertsen Norway 11 243 0.8× 247 1.0× 68 1.0× 62 1.1× 5 0.1× 22 367

Countries citing papers authored by GR Burmester

Since Specialization
Citations

This map shows the geographic impact of GR Burmester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GR Burmester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GR Burmester more than expected).

Fields of papers citing papers by GR Burmester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GR Burmester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GR Burmester. The network helps show where GR Burmester may publish in the future.

Co-authorship network of co-authors of GR Burmester

This figure shows the co-authorship network connecting the top 25 collaborators of GR Burmester. A scholar is included among the top collaborators of GR Burmester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GR Burmester. GR Burmester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weinblatt, M., et al.. (2018). Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials. Oxford University Research Archive (ORA) (University of Oxford). 2 indexed citations
2.
Strangfeld, Anja, Adrian Richter, B. Manger, et al.. (2017). FRI0130 Rates and risk factors of new-onset psoriasis under different biologic agents and conventional synthetic dmard treatment. Annals of the Rheumatic Diseases. 76. 530–530. 2 indexed citations
3.
Fleischmann, Roy, Paweł Hrycaj, Hubert van Hoogstraten, et al.. (2017). SAT0212 Sarilumab dose reduction in an open-label extension study in ra patients with inadequate response to tnf inhibitors. Annals of the Rheumatic Diseases. 76. 853–853. 1 indexed citations
4.
5.
Smiljanovic, Biljana, Bruno Stuhlmüller, Włodzimierz Maśliński, et al.. (2016). A6.07 Tissue- and cell-specific transcriptomes indicate systemic nature of ra and revealed combinations of protein biomarkers relevant for disease characterisation in serum. Annals of the Rheumatic Diseases. 75. A49–A50. 3 indexed citations
6.
7.
Burmester, GR, et al.. (2010). Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica.. PubMed. 28(5 Suppl 61). S172–7. 19 indexed citations
8.
Jacobi, Annett M., Henrik E. Mei, Bimba F. Hoyer, et al.. (2009). HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 69(1). 305–308. 132 indexed citations
9.
Pischon, Nicole, Tobias Pischon, E. Gülmez, et al.. (2009). Periodontal disease in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 69(1). 34–38. 36 indexed citations
10.
Häupl, Thomas, Bruno Stuhlmüller, Andreas Grützkau, Andreas Radbruch, & GR Burmester. (2009). Does gene expression analysis inform us in rheumatoid arthritis?. Annals of the Rheumatic Diseases. 69. i37–i42. 23 indexed citations
11.
Kalden, JR, et al.. (2009). Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial.. PubMed. 26(5). 834–40. 9 indexed citations
12.
Kellner, H., Johannes Strunk, Lukas Meier, et al.. (2008). Evaluation eines neuen 7-Gelenke-Ultraschall-Scores (US7) für die tägliche rheumatologische Praxis – ein Pilotprojekt in Deutschland. Ultraschall in der Medizin - European Journal of Ultrasound. 29(S 03). 1 indexed citations
13.
Spies, Cornelia M., D. Schaumann, Tímea Berki, et al.. (2006). Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway. Annals of the Rheumatic Diseases. 65(9). 1139–1146. 35 indexed citations
14.
Feist, Eugen, Gert Hausdorf, Karl Egerer, et al.. (2006). Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. Annals of the Rheumatic Diseases. 66(1). 5–11. 10 indexed citations
15.
Burmester, GR, Paul Emery, John D. Isaacs, et al.. (2006). Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF alpha therapies. 7 indexed citations
16.
Stuhlmüller, Bruno, Thomas Häupl, Neeraj Tandon, et al.. (2005). Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in rheumatoid arthritis. Arthritis Research. 7(Suppl 1). P159–P159. 3 indexed citations
17.
Dörner, Thomas, Annett M. Jacobi, Marcus Odendahl, et al.. (2003). Analysis of B-cell subpopulations in systemic lupus erythematosus. Arthritis Research. 5(Suppl 3). 27–27. 1 indexed citations
18.
Ungethüm, Ute, Thomas Häupl, Dirk Koczan, et al.. (2003). RA-specific expression profiles and new candidate genes. Arthritis Research. 5(Suppl 1). 81–81. 1 indexed citations
19.
Ungethüm, Ute, Thomas Häupl, J. Zacher, et al.. (2001). Patterns of differentially expressed genes in synovial tissue from RA and OA patients and from normal joints. Arthritis Research & Therapy. 3(S2). 1 indexed citations
20.
Jacobi, Annett M., W. Rohde, M Ventz, et al.. (2001). Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 10(8). 554–561. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A M Delgado-Vega Breakdown of academic impact, for papers by JT Merrill Breakdown of academic impact, for papers by Vicente Baca Breakdown of academic impact, for papers by Maiko Yoshikawa Breakdown of academic impact, for papers by Tiina M. Järvinen Breakdown of academic impact, for papers by Vasileios Vazgiourakis Breakdown of academic impact, for papers by F Navaux Breakdown of academic impact, for papers by Isabelle Lemaire Breakdown of academic impact, for papers by CWK Lam Breakdown of academic impact, for papers by Gro Østli Eilertsen
Rankless by CCL
2026